Back
covid-19 Non classé

Edouard Hueber

[Alerte actualité] Anticorps XAV19

30 avril 2020 Download the press release / Télécharger le communiqué

Read More

[Infographie] Traitement XAV19

Available here/Disponible ici

Read More

[Newsletter -1] NEWS / INFOS

May 1st, 2020. >> Official news bulletin for XAV19/Bulletin officiel du XAV19...

Read More

In the news / A la une

Journal des Entreprises – Coronavirus – XENOTHERA : « Nous prenons des risques entrepreneuriaux...

Read More

COVID19 / XAV19 : Scientific and medical rationale

Français ci-dessous «  We are convinced that our treatment will be efficient, for...

Read More

XENOTHERA announces receivability of its Clinical Trial Application at the Czech Republic regulatory agency for a first in man clinical trial of LIS1 in kidney transplanted patients with dose escalation.

Nantes, June 21st, 2019 – XENOTHERA announces receivability after its submission of a Clinical...

Read More

XENOTHERA

21 rue La Nouë de Fer, 44200 Nantes, France

contact@xenothera.com

Media : xenothera@izsogood.co

Linkedin-in